Gengos Andrew - Insider Non-Derivative Transactions at Athira Pharma, Inc. (ATHA) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Sep 5, 2024, Gengos Andrew's relationship to Athira Pharma, Inc. (ATHA) is Officer (CFO and Chief Business Officer), and currently has 97,532 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ATHA insiders.
Data Source: SEC.
Gengos Andrew - Insider Non-Derivative Transactions of ATHA Common Stock
Gengos Andrew - Insider Non-Derivative Transactions at ATHA
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Sep 6, 2024 | Sell -- (Common Stock) | 1272 | 0.57 | 97532 |
| Sep 4, 2024 | Acquisition -- (Common Stock) | 5000 | 0 | 98804 |
| May 21, 2024 | Acquisition -- (Common Stock) | 10000 | 1.34 | 93804 |
| Jan 6, 2024 | Sell -- (Common Stock) | 1208 | 2.91 | 83804 |
| Jan 5, 2024 | Acquisition -- (Common Stock) | 5000 | 0 | 85012 |
| Jun 8, 2023 | P -- (Common Stock) | 422 | 3.36 | 65434 |
| Jun 8, 2023 | P -- (Common Stock) | 2859 | 3.4 | 68293 |
| Jun 8, 2023 | P -- (Common Stock) | 11719 | 3.44 | 80012 |
| Jun 6, 2023 | P -- (Common Stock) | 15000 | 3 | 35012 |
| Jun 6, 2023 | P -- (Common Stock) | 10000 | 3 | 45012 |
| Jun 6, 2023 | P -- (Common Stock) | 10000 | 3 | 55012 |
| Jun 6, 2023 | P -- (Common Stock) | 10000 | 3.02 | 65012 |
| Jun 3, 2023 | P -- (Common Stock) | 10012 | 2.75 | 10012 |
| Jun 3, 2023 | P -- (Common Stock) | 6582 | 2.86 | 16594 |
| Jun 3, 2023 | P -- (Common Stock) | 3418 | 2.95 | 20012 |
| Jan 6, 2023 | Sell -- (Common Stock) | 1208 | 2.91 | 83804 |
| Jan 5, 2023 | Acquisition -- (Common Stock) | 5000 | 0 | 85012 |